Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy

NCT02460302 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Inadequate staffing and funds

Conditions

Atrophic Vaginitis
Menopause
Vulvovaginal Atrophy

Interventions

DRUG: Vaginal progesterone
DRUG: Placebo

Sponsor

Mount Sinai Hospital, Canada